Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results

Verastem, Inc. (VSTM) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/10/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/28/2023 8-K Quarterly results
08/10/2023 SC 13G/A BAKER BROS. ADVISORS LP reports a 0% stake in Verastem, Inc.
08/08/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/04/2023 4 Paterson Dan (President and CEO) has filed a Form 4 on Verastem, Inc.
Txns: Granted 50,000 shares @ $0
Granted 100,000 options to buy @ $10.44, valued at $1M
08/04/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Payments Subject to Section 409A"
07/27/2023 SC 13G Soleus Capital Master Fund, L.P. reports a 5.1% stake in Verastem, Inc.
07/12/2023 8-K Quarterly results
07/10/2023 4 Calkins Daniel (Vice President of Finance) has filed a Form 4 on Verastem, Inc.
Txns: Sold 5 shares @ $8.02, valued at $40.1
06/28/2023 4 Calkins Daniel (Vice President of Finance) has filed a Form 4 on Verastem, Inc.
Txns: Sold 26 shares @ $8.17, valued at $212.4
06/12/2023 SC 13G/A BAKER BROS. ADVISORS LP reports a 8% stake in Verastem, Inc.
06/08/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "LGSOC NSCLC 1H2022 RAMP 201"
06/05/2023 SC 13G VIKING GLOBAL INVESTORS LP reports a 7.9% stake in Verastem, Inc.
05/31/2023 8-K Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Yea...
Docs: "CERTIFICATE OF AMENDMENT TO THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION, AS AMENDED OF VERASTEM, INC.",
"Verastem Oncology Announces Reverse Stock Split"
05/25/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
05/16/2023 4 Bunn Paul A. (Director) has filed a Form 4 on Verastem, Inc.
Txns: Granted 62,500 options to buy @ $0.42, valued at $26.3k
05/16/2023 4 Rowinsky Eric K (Director) has filed a Form 4 on Verastem, Inc.
Txns: Granted 62,500 options to buy @ $0.42, valued at $26.3k
05/16/2023 4 Kauffman Michael (Director) has filed a Form 4 on Verastem, Inc.
Txns: Granted 62,500 options to buy @ $0.42, valued at $26.3k
05/16/2023 4 Kapur Anil (Director) has filed a Form 4 on Verastem, Inc.
Txns: Granted 62,500 options to buy @ $0.42, valued at $26.3k
05/16/2023 4 JOHNSON JOHN (Director) has filed a Form 4 on Verastem, Inc.
Txns: Granted 62,500 options to buy @ $0.42, valued at $26.3k
05/16/2023 4 Gagnon Robert E. (Director) has filed a Form 4 on Verastem, Inc.
Txns: Granted 62,500 options to buy @ $0.42, valued at $26.3k
05/16/2023 4 ROBERTSON MICHELLE (Director) has filed a Form 4 on Verastem, Inc.
Txns: Granted 62,500 options to buy @ $0.42, valued at $26.3k
05/16/2023 4 Tollefson Karin Anna (Director) has filed a Form 4 on Verastem, Inc.
Txns: Granted 187,500 options to buy @ $0.42, valued at $78.8k
05/16/2023 3 Tollefson Karin Anna (Director) has filed a Form 3 on Verastem, Inc.
05/16/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
05/09/2023 10-Q Quarterly Report for the period ended March 31, 2023
04/25/2023 EFFECT Form EFFECT - Notice of Effectiveness:
04/24/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
04/18/2023 S-3/A Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
04/06/2023 4 Calkins Daniel (Vice President of Finance) has filed a Form 4 on Verastem, Inc.
Txns: Sold 75 shares @ $0.37, valued at $27.8
04/05/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/28/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/27/2023 8-K Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant ...
03/24/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy